Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Fallopian Tube Neoplasms × sapanisertib × Clear all

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Advanced Nonhematologic Malignancies 2 Waldenstrom Macroglobulinemia 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Somatostatinoma 1 Recurrent Malignant Solid Neoplasm 1 Recurrent Lung Squamous Cell Carcinoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Non-hematologic Malignancy 1 Neoplasms 1 Multiple Myeloma 1 Metastatic Castration-Resistant Prostate Cancer 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Fibrolamellar hepatocellular carcinoma 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Burkitt Lymphoma 1 Advanced Solid Tumors 1 Advanced Solid Malignancies 1 Adenoma, Islet Cell 1

Interventions

Carboplatin 78 Paclitaxel 65 Bevacizumab 34 Topotecan 21 Gemcitabine 21 liposomal doxorubicin 18 Taxes 17 Cisplatin 16 Docetaxel 12 Cyclophosphamide 12 pembrolizumab 11 Immunoglobulin G 10 Drug Therapy 10 Disulfides 10 mirvetuximab soravtansine 8 veliparib 7 Albumin-Bound Paclitaxel 7 sargramostim 6 rucaparib 6 niraparib 6 Erlotinib Hydrochloride 6 Doxorubicin 6 Granulocyte-Macrophage Colony-Stimulating Factor 5 Chemotherapy, Adjuvant 5 CP protocol 5 trebananib 4 temsirolimus 4 pazopanib 4 durvalumab 4 aflibercept 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03648489 2024-09-20

DICE

Imperial College London

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡